TR201900220T4 - Ani ilaç salım kompozisyonları. - Google Patents

Ani ilaç salım kompozisyonları. Download PDF

Info

Publication number
TR201900220T4
TR201900220T4 TR2019/00220T TR201900220T TR201900220T4 TR 201900220 T4 TR201900220 T4 TR 201900220T4 TR 2019/00220 T TR2019/00220 T TR 2019/00220T TR 201900220 T TR201900220 T TR 201900220T TR 201900220 T4 TR201900220 T4 TR 201900220T4
Authority
TR
Turkey
Prior art keywords
drug release
release compositions
active ingredient
pharmaceutically active
immediate drug
Prior art date
Application number
TR2019/00220T
Other languages
English (en)
Inventor
Kinter Kevin
Ramsey Peter
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of TR201900220T4 publication Critical patent/TR201900220T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)

Abstract

En az bir farmasötik açıdan aktif muhteviyat ve en az bir kontrollü salım ajanı içeren bir katı doz kompozisyonu ve adı geçen kompozisyonu üretme yöntemi açıklanır. Kompozisyon içindeki en az bir farmasötik açıdan aktif muhteviyatın patlama profili, kontrollü salım ajanının görünür viskozitesi ile düzenlenir ve buradaki en az bir farmasötik açıdan aktif muhteviyat, ıslak granülasyon yoluyla işlenir.
TR2019/00220T 2009-05-13 2010-05-13 Ani ilaç salım kompozisyonları. TR201900220T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17794309P 2009-05-13 2009-05-13

Publications (1)

Publication Number Publication Date
TR201900220T4 true TR201900220T4 (tr) 2019-02-21

Family

ID=42647324

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/00220T TR201900220T4 (tr) 2009-05-13 2010-05-13 Ani ilaç salım kompozisyonları.

Country Status (23)

Country Link
US (2) US20100311839A1 (tr)
EP (2) EP3459530B1 (tr)
JP (2) JP5740396B2 (tr)
KR (1) KR101471240B1 (tr)
CN (2) CN107028909A (tr)
AR (1) AR076907A1 (tr)
AU (1) AU2010248979A1 (tr)
BR (1) BRPI1010987B8 (tr)
CA (1) CA2761795C (tr)
CO (1) CO6390100A2 (tr)
ES (1) ES2707275T3 (tr)
HU (2) HUE053202T2 (tr)
IL (1) IL216186B (tr)
MX (1) MX336065B (tr)
NZ (1) NZ596275A (tr)
PL (1) PL2429501T3 (tr)
PT (1) PT2429501T (tr)
RU (2) RU2541807C2 (tr)
SG (2) SG10201402285XA (tr)
TR (1) TR201900220T4 (tr)
TW (1) TWI478733B (tr)
WO (1) WO2010132635A1 (tr)
ZA (1) ZA201109084B (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
JP7083312B2 (ja) * 2016-04-26 2022-06-10 エルテーエス ローマン テラピー－ジステーメ アーゲー 抗糖尿病ペプチドの経粘膜送達用のフィルム状投与形態
CN117017932B (zh) * 2023-08-24 2024-05-24 浙江和沐康医药科技有限公司 一种舒林酸片组合物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786503A (en) * 1987-04-06 1988-11-22 Alza Corporation Dosage form comprising parallel lamine
US4983398A (en) * 1987-12-21 1991-01-08 Forest Laboratories, Inc. Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates
JPH01319416A (ja) * 1988-06-21 1989-12-25 Dai Ichi Kogyo Seiyaku Co Ltd 放出制御可能な錠剤結合剤
JPH05255125A (ja) * 1992-02-29 1993-10-05 Upjohn Co:The 徐放性製剤およびその製法
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US8293277B2 (en) * 1998-10-01 2012-10-23 Alkermes Pharma Ireland Limited Controlled-release nanoparticulate compositions
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
AR034517A1 (es) * 2001-06-21 2004-02-25 Astrazeneca Ab Formulacion farmaceutica
US20040101494A1 (en) * 2002-11-26 2004-05-27 Scott Douglas Craig Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth
US20040265373A1 (en) * 2003-06-27 2004-12-30 David Wynn Soft tablet containing high molecular weight cellulosics
US20060068009A1 (en) * 2004-09-30 2006-03-30 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet

Also Published As

Publication number Publication date
RU2014146936A3 (tr) 2018-06-04
EP2429501B1 (en) 2018-11-21
RU2014146936A (ru) 2016-06-10
CN102458375A (zh) 2012-05-16
ES2707275T3 (es) 2019-04-03
IL216186B (en) 2019-10-31
IL216186A0 (en) 2012-01-31
CA2761795A1 (en) 2010-11-18
CA2761795C (en) 2017-02-21
JP2015155452A (ja) 2015-08-27
RU2541807C2 (ru) 2015-02-20
SG10201402285XA (en) 2014-08-28
CN107028909A (zh) 2017-08-11
KR101471240B1 (ko) 2014-12-09
KR20120012485A (ko) 2012-02-10
BRPI1010987B1 (pt) 2020-06-02
US20100311839A1 (en) 2010-12-09
MX336065B (es) 2016-01-06
EP2429501A1 (en) 2012-03-21
RU2011145436A (ru) 2013-06-20
US20130116327A1 (en) 2013-05-09
EP3459530A1 (en) 2019-03-27
AR076907A1 (es) 2011-07-20
PL2429501T3 (pl) 2019-06-28
WO2010132635A1 (en) 2010-11-18
EP3459530B1 (en) 2020-09-23
ZA201109084B (en) 2012-08-29
JP2012526841A (ja) 2012-11-01
TW201105367A (en) 2011-02-16
AU2010248979A1 (en) 2011-11-24
BRPI1010987B8 (pt) 2021-05-25
BRPI1010987A2 (pt) 2019-04-02
HUE053202T2 (hu) 2021-06-28
MX2011012045A (es) 2011-12-12
PT2429501T (pt) 2019-01-30
HUE042857T2 (hu) 2019-07-29
JP5740396B2 (ja) 2015-06-24
SG175892A1 (en) 2011-12-29
TWI478733B (zh) 2015-04-01
CO6390100A2 (es) 2012-02-29
NZ596275A (en) 2014-01-31

Similar Documents

Publication Publication Date Title
WO2011051354A3 (en) Transdermal pharmaceutical compositions comprising active agents
AR047993A1 (es) Composicion farmaceutica que comprende pimobendano
WO2012034079A3 (en) Macrolide dosage forms
CL2013001586A1 (es) Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion.
CU24065B1 (es) Forma de dosificación farmacéutica que comprende nifedipino y un antagonista de angiotensina ii
AR062710A1 (es) Formulaciones de un compuesto en forma de polvo seco y usos de estas
WO2009063222A3 (en) Solid compositions
WO2011099832A3 (en) Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same
IN2012DN00570A (tr)
FR2928836B1 (fr) Forme galenique secable permettant une liberation modifiee du principe actif
ECSP11011023A (es) Tratamiento sistémico de parásitos hematófagos y consumidores de sangre por administración oral de un agente antiparasitario
MX2011011829A (es) Composicion para suministro sostenido de farmaco que comprende un aglutinante geopolimerico.
MY159492A (en) Solid pharmaceutical formulation with delayed release
MX365313B (es) Composición farmacéutica oral que comprende a,a,a-trifluorotimidin a y clorhidrato de 5-cloro-6-(2-iminopirrolidina-1-il)metil-2,4(1h ,3h)-pirimidina diona.
FR2915683B1 (fr) Formulations pharmaceutiques auto-precipitantes pour la liberation modifiee de principe actif
MX2012007365A (es) Composiciones farmaceuticas de liberacion lenta de iloperidona.
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
MY191875A (en) Solid dosage form
MD4563B1 (ro) Produs de comicronizare cu conţinut de acetat de ulipristal
BRPI0920683A2 (pt) Composto, composição de composto ativo, semente, medicamento, e, métodos para controlar fungos fitopatogênicos, e para preparar um agente antimicótico
TR201900220T4 (tr) Ani ilaç salım kompozisyonları.
MX346316B (es) Formulacion farmaceutica o nutraceutica.
MX2009005329A (es) Composiciones farmaceuticas anticonvulsivas.
WO2010110518A1 (ko) 항진균 조성물
TH128132B (th) องค์ประกอบสำหรับการปลดปล่อยยาฉับพลัน